Seagen
SGEN
$228.74
Share price
-0.07%
Change (1 day)
68.92%
Change (1 year)
Categories
Seagen (SGEN) - Total liabilities
Total liabilities on the balance sheet as of September 2023 : $1.08 B
According to Seagen 's latest financial reports the company's total liabilities are $1.08 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Seagen - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.87 B | 33.04% |
| 2021-12-31 | $0.65 B | 27.62% |
| 2020-12-31 | $0.51 B | 55.59% |
| 2019-12-31 | $0.32 B | 43.68% |
| 2018-12-31 | $0.22 B | 14.48% |
| 2017-12-31 | $0.20 B | -1.92% |
| 2016-12-31 | $0.20 B | -2.33% |
| 2015-12-31 | $0.20 B | -15.7% |
| 2014-12-31 | $0.24 B | -2.2% |
| 2013-12-31 | $0.25 B | 3.44% |
| 2012-12-31 | $0.24 B | 18.85% |
| 2011-12-31 | $0.20 B | 22.53% |
| 2010-12-31 | $0.16 B | -7.53% |
| 2009-12-31 | $0.18 B | 67.56% |
| 2008-12-31 | $0.10 B | 14.97% |
| 2007-12-31 | $94.54 M | 899.3% |
| 2006-12-31 | $9.46 M | -35.03% |
| 2005-12-31 | $14.56 M | -4.68% |
| 2004-12-31 | $15.27 M | 114.52% |
| 2003-12-31 | $7.12 M | 22.06% |
| 2002-12-31 | $5.83 M | 147.51% |
| 2001-12-31 | $2.35 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $137.21 B | 12,559.89% | 🇺🇸 USA |
 AbbVie ABBV | $124.31 B | 11,369.77% | 🇺🇸 USA |
 Biogen BIIB | $12.04 B | 1,011.36% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $65.67 B | 5,959.38% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | 5,327.49% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | $80.87 M | -92.54% | 🇺🇸 USA |
 ImmunoGen
IMGN | $0.26 B | -75.96% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | $36.45 M | -96.64% | 🇺🇸 USA |